Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Mon, 22.01.2024
LION E-Mobility AG
A new CEO to kick off the year
Topic: LION announced to have a singed a highly qualified successor for the
current CEO, which is leaving at the end of January. Following LION‘s major
transformation last year, the company looks poised for strong growth.
At the end of November, LION announced the departure of its CEO Winfried
Buss end of [ … ]
Fri, 19.01.2024
Cardiol Therapeutics Inc
First Berlin Equity Research has published a research update on Cardiol
Therapeutics Inc. (ISIN: CA14161Y2006). Analyst Christian Orquera
reiterated his BUY rating and maintained his USD 3.60 price target.
Abstract:
Cardiol Therapeutics (Cardiol) has completed >50% of patient recruitment
for CardiolRx's two lead indications, acute myocarditi [ … ]
Fri, 19.01.2024
Netfonds AG
Strategic acquisition to improve profitability; chg
Yesterday, Netfonds announced to have acquired a majority stake in “Meine
Finanzkanzlei GmbH” (“MFK”) through its fully owned subsidiary NVS Netfonds
Versicherungsservice AG. In detail:
We assume that Netfonds has acquired a stake of 65-85% (eNuW) at a low to
mid, sin [ … ]
Fri, 19.01.2024
Flughafen Wien AG
FY’24 guidance out – solid outlook for the year
Topic: FWAG released its FY ’24 guidance, indicating a solid outlook for
the year. Moreover, Dec ’23 traffic results came in slightly better than
expected.
Guidance in line with estimates: FWAG expects c. € 970m sales (eNuW: €
965m), at least € 390m EBITDA [ … ]
Thu, 18.01.2024
MAX Automation SE
MAX lays the foundation for outperformance in 2024
Topic: MAX Automation has another promising year in front of it. We expect
the company to grow its topline by 7% in 2024e while sustaining last year’s
profitability (eNuW).
Topline growth ahead: With several structural trends kicking in, MAX should
be able to grow its revenue in the cur [ … ]
Wed, 17.01.2024
THE NAGA GROUP AG
Strong FY23 prelims and merger with Capex.com; chg
Last week, NAGA reported preliminary FY23 figures that came stronger than
expected. Further, the company has announced (at the end of 2023) a planned
business combination with Capex.com. In detail:
- Sales came in at € 45.5m (-21% yoy), significantly above our estimates of
€ 38.1m. [ … ]
Wed, 17.01.2024
INDUS Holding AG
Another promising year for INDUS
Topic: While INDUS should experience some margin pressure in 2024e, the
EBIT margin is still seen to come in at 8.0%, which is the highest
operating margin since 2017. With an appealing dividend yield of 5.5%
(eNuW) and an attractive valuation of only 4.6x EV/EBITDA, the stock
remains a buy.
Normalizing margin [ … ]
Tue, 16.01.2024
Cenit AG
First acquisition of 2024 strengthens the 3DS Solutions division; forecasts
and target price unchanged
As expected, CENIT AG is continuing the high level of acquisition activity
implemented since the 2022 financial year in the 2024 financial year. As
the company announced in the second calendar week of the still young year,
CCE b:digital G [ … ]
Tue, 16.01.2024
urban-gro, Inc
First Berlin Equity Research hat ein Research Update zu urban-gro, Inc.
(ISIN: US91704K2024) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und bestätigt sein Kursziel von USD 4,70.
Zusammenfassung:
urban-gro hat das neue Jahr mit einem Design-Build-Auftrag im Wert von ca.
$20 Mio. begonnen. Der in den USA an [ … ]
Tue, 16.01.2024
DEMIRE AG
LogPark finally sold + letting success to start crucial 2024
After the disposal of the LogPark in Leipzig to CommerzReal initially fell
through in July 2023, DEMIRE has now found a new buyer, namely HIH Invest
Real Estate. We estimate the purchase price, which was not disclosed, to be
in the range of € 100-105m, hence being some 15% below [ … ]